Britt J C, Park S S
Department of Otolaryngology-Head and Neck Surgery, University of Virginia Medical Center, Charlottesville 22906-0008, USA.
Arch Otolaryngol Head Neck Surg. 1998 Jun;124(6):671-7. doi: 10.1001/archotol.124.6.671.
To determine whether autogenous tissue-engineered cartilage grafts can be synthesized in predetermined shapes, to compare tissue-engineered cartilage with native cartilage with respect to histological characteristics and biomechanical properties, and to demonstrate how multiple transplantations affect tissue-engineered cartilage.
Controlled, prospective animal study.
Twenty New Zealand white rabbits, 3 weeks old.
Autogenous chondrocytes were seeded onto biodegradable polyglycolic acid-poly-L-lactic acid copolymer templates in 1 of 3 shapes (cross, nasal tip graft, or auricle). Grafts and controls of sculpted cartilage were divided among 3 groups: short-term implantation (4 or 8 weeks), long-term implantation (6 or 12 months), and a reimplantation group. The gross morphological features, histological findings, and tensile strength of grafts were assessed.
Production of tissue-engineered cartilage was confirmed in 30 of 31 implants. Histological evaluation demonstrated characteristic cartilaginous matrix, but with prominent vascular and fibrous tissue ingrowth. In long-term implantation grafts (n=4), foci of osteoid were evident by 6 months. In the subset of transplanted grafts (n=7), 5 of 7 demonstrated significant loss of cartilage viability. Tensile strength measurements demonstrated values 24% and 41% of those of controls at 4 and 8 weeks, respectively.
Tissue-engineered autogenous cartilage can be reliably produced, and predetermination of graft shape is possible. Histologically, grafts represent composites of mature cartilage infiltrated by vasculature and fibrous tissue, with delayed osteoid formation. Graft viability is compromised by early transplantation, and tensile strength is less than that of native cartilage. These results demonstrate the feasibility of tissue-engineered cartilage as a future graft material.
确定自体组织工程软骨移植物能否被合成预定形状,比较组织工程软骨与天然软骨在组织学特征和生物力学特性方面的差异,并证明多次移植如何影响组织工程软骨。
对照、前瞻性动物研究。
20只3周龄的新西兰白兔。
将自体软骨细胞接种到3种形状(十字形、鼻尖移植物或耳廓)之一的可生物降解聚乙醇酸-聚-L-乳酸共聚物模板上。将雕刻软骨的移植物和对照分为3组:短期植入(4周或8周)、长期植入(6个月或12个月)和再植入组。评估移植物的大体形态特征、组织学发现和拉伸强度。
31个植入物中有30个证实产生了组织工程软骨。组织学评估显示有特征性的软骨基质,但有明显的血管和纤维组织长入。在长期植入移植物(n = 4)中,6个月时可见类骨质灶。在移植移植物亚组(n = 7)中,7个中有5个显示软骨活力明显丧失。拉伸强度测量显示,在4周和8周时,其值分别为对照的24%和41%。
可以可靠地生产组织工程自体软骨,并且移植物形状的预先确定是可行的。从组织学上看,移植物是成熟软骨与血管和纤维组织浸润的复合物,类骨质形成延迟。早期移植会损害移植物的活力,并且拉伸强度低于天然软骨。这些结果证明了组织工程软骨作为未来移植物材料的可行性。